example 11 [WO2019174577A1]
6-[[3-[5-(methoxymethyl)-1,2-oxazol-3-yl]-[1,2,4]triazolo[3,4-a]phthalazin-6-yl]oxymethyl]-N-propan-2-ylpyridine-3-carboxamide
Molecular Identity
example 11 [WO2019174577A1]
6-[[3-[5-(methoxymethyl)-1,2-oxazol-3-yl]-[1,2,4]triazolo[3,4-a]phthalazin-6-yl]oxymethyl]-N-propan-2-ylpyridine-3-carboxamide
PubChem CID: 139494025
2D Structure
Properties
C24H23N7O4
Molecular Formula
473.50
Molecular Weight
g/mol
473.1812
Exact Mass
Da
1.7
XLogP
Drug-like (Lipinski: < 5)
130
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
9
H-Bond Acceptors
715
Complexity
SMILES
Canonical SMILES
SMILES: CC(C)NC(=O)C1=CN=C(C=C1)COC2=NN3C(=NN=C3C4=NOC(=C4)COC)C5=CC=CC=C52Isomeric SMILES
SMILES: CC(C)NC(=O)C1=CN=C(C=C1)COC2=NN3C(=NN=C3C4=NOC(=C4)COC)C5=CC=CC=C52Synonyms(7)
SCHEMBL21362667GTPL13982SR419SR 419SR-419example 11 [WO2019174577A1]6-[[3-[5-(methoxymethyl)-1,2-oxazol-3-yl]-[1,2,4]triazolo[3,4-a]phthalazin-6-yl]oxymethyl]-N-propan-2-ylpyridine-3-carboxamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to example 11 [WO2019174577A1]
Loading drug network...